Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBurcham, Philip Cyrilen
dc.contributor.authorRaso, Alberten
dc.contributor.authorKaminskas, Lisa Michelleen
dc.identifier.citationMolecular Pharmacology, 2012; 82(5):876-886en
dc.description.abstractToxic carbonyls such as acrolein participate in many degenerative diseases. Although the nucleophilic vasodilatory drug hydralazine readily traps such species under “test-tube” conditions, whether these reactions adequately explain its efficacy in animal models of carbonyl-mediated disease is uncertain. We have previously shown that hydralazine attacks carbonyl-adducted proteins in an “adduct-trapping” reaction that appears to take precedence over direct “carbonyl-sequestering” reactions, but how this reaction conferred cytoprotection was unclear. This study explored the possibility that by increasing the bulkiness of acrolein-adducted proteins, adduct-trapping might alter the redistribution of chaperones to damaged cytoskeletal proteins that are known targets for acrolein. Using A549 lung adenocarcinoma cells, the levels of chaperones heat shock protein (Hsp) 40, Hsp70, Hsp90, and Hsp110 were measured in intermediate filament extracts prepared after a 3-h exposure to acrolein. Exposure to acrolein alone modestly increased the levels of all four chaperones. Coexposure to hydralazine (10–100 μM) strongly suppressed cell ATP loss while producing strong adduct-trapping in intermediate filaments. Most strikingly, hydralazine selectively boosted the levels of cytoskeletal-associated Hsp90, including a high-mass species that was sensitive to the Hsp90 inhibitor 17-N-allylamino-17-demethoxygeldanamycin. Biochemical fractionation of acrolein- and hydralazine-treated cells revealed that hydralazine likely promoted Hsp90 migration from cytosol into other subcellular compartments. A role for Hsp90 mobilization in cytoprotection was confirmed by the finding that brief heat shock treatment suppressed acute acrolein toxicity in A549 cells. Taken together, these findings suggest that by increasing the steric bulk of carbonyl-adducted proteins, adduct-trapping drugs trigger the intracellular mobilization of the key molecular chaperone Hsp90.en
dc.description.statementofresponsibilityPhilip C. Burcham, Albert Raso and Lisa M. Kaminskasen
dc.publisherAmerican Society for Pharmacology and Experimental Therapeuticsen
dc.rightsCopyright © 2012 The American Society for Pharmacology and Experimental Therapeuticsen
dc.titleChaperone heat shock protein 90 mobilization and hydralazine cytoprotection against acrolein-induced carbonyl stressen
dc.typeJournal articleen
dc.contributor.schoolSchool of Medical Sciences : Pharmacologyen
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.